Cargando…
Current results and remaining challenges of trans-catheter aortic valve replacement expansion in intermediate and low risk patients
TAVR has become the standard treatment in patients at increased surgical risk (STS or EuroSCORE II ≥4% or logistic EuroSCORE I ≥ 10% or other risk factors not included in these scores such as frailty, porcelain aorta, sequelae of chest radiation) and it is increasingly being performed in patients at...
Autores principales: | Ielasi, Alfonso, Latib, Azeem, Tespili, Maurizio, Donatelli, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6525308/ https://www.ncbi.nlm.nih.gov/pubmed/31193348 http://dx.doi.org/10.1016/j.ijcha.2019.100375 |
Ejemplares similares
-
Trans-Catheter Valve-in-Valve Implantation for the Treatment of Aortic Bioprosthetic Valve Failure
por: Buono, Andrea, et al.
Publicado: (2022) -
An Update on New Generation Transcatheter Aortic Valves and Delivery Systems
por: Santangelo, Gloria, et al.
Publicado: (2022) -
Editorial: Percutaneous Mitral Valve Interventions (Repair): Current Indications and Future Perspectives
por: Ielasi, Alfonso, et al.
Publicado: (2020) -
Transcatheter Mitral Valve Replacement in the Transcatheter Aortic Valve Replacement Era
por: Testa, Luca, et al.
Publicado: (2019) -
Clinical Comparison of a Novel Balloon-Expandable Versus a Self-Expanding Transcatheter Heart Valve for the Treatment of Patients with Severe Aortic Valve Stenosis: The EVAL Registry
por: Barki, Monica, et al.
Publicado: (2022)